Capitalizing on genomic/proteomic data to treat and cure infectious diseases by bringing in to play our knowledge regarding naturally occurring infectious disease resistant genotypes/phenotypes and gene therapy
patient where the genotype had been manipulated employing CRISPR or other gene manipulating tools and then replace the manipulated cells in the bone marrow of the subject so that they ... IntAct contribute to the Second…

